BothCases
Example report. Sign up to run the same analysis on any ticker.
NVDA logoNVDAEquity research

Report date: 2026-11-14

$127.91-18.07 (-12.38%)Live · delayed quote, informational only

Analysis focus

Provide a balanced, comprehensive analysis: fundamentals and valuation, the Wall Street view, technical posture, and the key forward risks and catalysts.

Summary

NVDA's latest reported fundamentals remain very strong, even with the stock in a sharp drawdown. In fiscal Q2 FY2027 (quarter ended July 26, 2026), revenue was $96.2B, up 106% year over year. Data Center revenue was $89.0B, up 117%, and gross margin was 75.0% [1][10]. One item needs normalizing: GAAP diluted EPS of $2.46 was above non-GAAP EPS of $2.22, largely because of about $7.8B of pre-tax gains on equity investments. That gain is non-operating, so $2.22 is the cleaner measure of operating earnings, still up about 120% [1][10]. Cash generation is large: trailing-twelve-month free cash flow is $127.01B, with about $23.61B of net cash ($62.47B cash against $38.86B debt) [19]. There are cash-quality warnings, though. Q2 free cash flow of $21.3B grew about 59% while revenue grew 106% [10], days-sales-outstanding has risen to 60, and about $50B has been invested in frontier AI labs [19]. The annual dividend is listed at $1.00 per share (0.61% yield) [18], which is negligible as a valuation support. On valuation, multiples have compressed sharply. At about $163 the stock trades at roughly 20.6x trailing earnings, 13.5x forward earnings, 17.5x book and 19.3x EV/EBITDA [11]. One outlet puts it at about 10.7x consensus FY2028 EPS of $15.75, and cites FactSet's next-twelve-month P/E of about 11.7x as the lowest since October 2011 [13]. For comparison, the S&P 500 is at roughly 18.7–20x, Broadcom about 19x and AMD between 27x and 32x depending on the source [13][21]. The case for holding or for the market having overshot rests on several points. The low multiple sits against guidance for further growth: Q3 revenue guidance is $108.0B ±2% ($105.84–$110.16B) at a 74.0% ±50bp gross margin, and that guidance excludes China data-center compute sales [1][2]. Management has also pointed to about 70% revenue growth in FY2028 and a Vera Rubin product ramp [5]. Sell-side sentiment is still overwhelmingly positive. Aggregators count roughly 59 Buy or Strong Buy ratings against 3 Hold and 1 Sell, with about 95% rated Buy [4][15]. Average targets range from about $271.64 to $326.92 depending on the aggregator and date, about $285–$290 on the main ones, which implies roughly 75–80% upside from the Nov 13 close [4][20]. Several large banks kept Buy-equivalent ratings with targets near $285–$300 [6]. Morgan Stanley described its removal of NVDA from its top-picks list as rule-driven rather than a change in its AI-buildout view [7]. Technically, the stock is deeply oversold. RSI(14) readings run from about 24.9 to 41.5 across sources [5][9], and the Nov 13 close of $162.85 is about 9% above the $148.81 52-week low, the nearest major support [16]. The case for selling or reducing exposure is also substantial. The stock closed at $162.85 on Nov 13, down 31.9% from its $239.24 record close on Oct 6 and down 21.2% since Nov 3 alone [8]. That drawdown erased close to $1.4T of market value [7]. Price sits about 20% below a 200-day average of roughly $204–$213, so the trend is clearly down [5][9]. Analyst momentum has turned negative. Baird downgraded to Neutral and cut its target 60%, from $500 to $200, citing limited 2027 supply visibility, hyperscaler capex growth slowing to about 40% or less, and uncertainty over CEO tenure [12]. Citi cut to $285 from $315 and Wells Fargo trimmed to $300 [6]. On Nov 12, BofA reportedly cut to $280 from $350 [20]. Over the past 90 days the major-bank actions were cuts or reiterations, not raises [6]. Governance risk is new and unresolved. Reuters-reported headlines about Jensen Huang led to an independent board investigation, a 4.3% one-day drop on Nov 9 (about $190B of market value) and a shareholder lawsuit [17]. Reports of his resignation are unconfirmed [17]. Other risks: gross margin is expected to bottom at 71–72% in Q4 on memory costs, along with supply constraints, China export rules and data-center power regulation [5][14]. A beta of 2.25 amplifies moves in either direction [5]. The next catalyst is Q3 FY2027 earnings on November 17, 2026, after the close [2][14]. Consensus of about $108.8–$109B revenue and $2.47–$2.49 EPS sits above the guidance midpoint [2][3][14]. That leaves little room for a disappointing result or outlook while the stock is technically weak, and a strong print could just as easily trigger a sharp rebound from oversold levels.

Findings (21)

In fiscal Q2 2027 NVDA reported revenue of $96.2 billion (+106% year over year), data-center revenue of about $89 billion (+117%) and adjusted EPS of $2.22 (+120%), and its fiscal Q3 guidance is $105.84–$110.16 billion of revenue, assuming no China data-center compute sales.

High confidence

The Fool and Crypto Briefing both report $96.2B revenue up 106% and data-center sales of $89B, and the Fool notes the roughly $108B guide excludes China data-center sales. The sources cite no one-time items such as legal settlements or asset sales in the Q2 result, but excluding China from guidance is a scope assumption to note when comparing results with the guide.

The next major catalyst is Q3 FY2027 earnings on November 17, 2026, after the close: company guidance is $108.0 billion of revenue ±2% and a 74.0% gross margin ±50 basis points, against consensus of about $108.8 to $109 billion of revenue and $2.47 to $2.48 of adjusted EPS.

High confidence

The primary 8-K gives the Q3 outlook of $108.0 billion ±2% and a 74.0% gross margin ±50 basis points. OANDA gives the consensus range and notes the guidance excludes China Data Center compute sales. MarketBeat and OANDA list the November 17 date. Consensus above the guidance midpoint leaves little room for a guidance miss while the stock is technically weak.

The most recent reported quarter, fiscal Q2 FY2027, brought $96.2 billion of revenue, including $89 billion from data center; fiscal Q3 is due after the close on November 17, 2026, against guidance of $108 billion ±2% at a 74% ±50bp gross margin and consensus EPS of about $2.47–$2.49.

Medium confidence

Secondary previews cite fiscal Q2 revenue of $96.2B ($89B data center), Q3 guidance of $108B ±2% excluding China/Hong Kong data-center compute, and 74% gross margin guidance; TipRanks lists $2.47 consensus EPS. Fiscal Q2 GAAP/non-GAAP EPS and any one-time items could not be confirmed from the primary release in this search pass, so no one-time-item adjustment can be stated.

Wall Street remains overwhelmingly positive on NVDA: StockAnalysis and Investing.com put the average 12-month target at $285.35 (range $174–$515), while a separate Nov 13 tally counted 59 Buy/Strong Buy ratings against one Sell and cited a higher $326.92 consensus.

Medium confidence

Investing.com (53 analysts) and StockAnalysis (61 analysts) both show $285.35, with Oppenheimer's $515 as the Street high. Public.com shows $271.64 from 36 analysts, and 24/7 Wall St. cites $326.92 alongside a 49 Buy / 10 Strong Buy / 1 Sell split. The spread reflects aggregators updating at different times and should not be treated as a single figure.

Technically, NVDA is deeply oversold and in a downtrend: at $162.85 it sits about 24% below its 50-day moving average ($214.65) and 20% below its 200-day moving average ($204.19), with a 14-day RSI of 24.86 after falling about 27% in one month.

High confidence

StockAnalysis lists the 50DMA at $214.65, the 200DMA at $204.19, RSI 24.86, a 5-year beta of 2.25 and a 52-week change of -15.97%. 24/7 Wall St. reports a 26.95% one-month decline and a 17.11% one-week decline amid an AI-chip selloff, and flags these risks: gross margin bottoming at 71–72% in Q4 on memory costs, supply constraints and China export rules. Its catalysts are the Vera Rubin ramp and management's outlook for about 70% FY2028 revenue growth.

Most major banks still have Buy-equivalent ratings with targets of $285–$300, about 60–70% above the roughly $177 price of November 11, 2026: Goldman Sachs reiterated Buy/$300 on November 9, Morgan Stanley kept Overweight/$300 on November 11, Wells Fargo trimmed its target by $15 to $300 on November 10, and Citi cut its target to $285 from $315 while keeping Buy.

Medium confidence

The Fool confirms Morgan Stanley's $300 target (about 70% upside) and Wells Fargo's $15 trim to $300. Crypto Briefing reports Goldman's $300 reiteration, and Goldman had raised its target from $285 to $300 in August 2026. The Citi cut (analyst Atif Malik) comes from aggregator coverage only. No action from JPMorgan, BofA or Barclays in the last 90 days could be verified. In the last 90 days the major-bank actions were cuts or reiterations, not raises.

Morgan Stanley removed NVDA from its top-picks list on November 11, 2026 after the stock fell more than 25% from its October 6, 2026 record close of $239.24, a drawdown that erased close to $1.4 trillion of market value.

High confidence

The Fool gives the $239.24 record close on Oct 6 and a price about 26% below it, and says Morgan Stanley described the top-pick removal as rule-driven rather than a change in its AI-buildout view. Crypto Briefing reports about $1.4 trillion in lost market value and a $180–$200 trading range by Nov 5. On technicals, the stock trades well below its October peak, though it bounced about 5% on Nov 11.

NVDA closed at $162.85 on November 13, 2026, down 21.2% from its $206.69 close on November 3, 2026, and down 31.9% from its highest close in the available data, $239.24 on October 6, 2026.

High confidence

StockAnalysis's daily history lists closes of $206.69 (Nov 3), $181.60 (Nov 5, a 9.26% one-day drop), $166.19 (Nov 12) and $162.85 (Nov 13), with the highest close in its Sep 4 to Nov 13 window at $239.24 on Oct 6. Investing.com puts the Nov 13 close slightly lower at about $162.63. The percentage changes are calculated from these closes. Clean 6-month and 12-month returns could not be confirmed from an accessible source.

NVDA trades below its 200-day simple moving average, which sources put at about $204 to $213, and its RSI(14) readings range from 26.9 to 41.5 across sources, so momentum is weak to oversold; values below 30 are conventionally read as oversold.

Medium confidence

Investing.com shows a 200-day of 210.04 and RSI(14) of 37.6. Financhill shows a 200-day of 204.47 and RSI(14) of 28.74 at a $173.73 price. Altindex shows RSI 26.9 and calls it oversold. The sources disagree on the 50-day average (Investing.com about $181, Financhill about $217, Algovestiq about $221), so its level is uncertain. All usable USD sources agree the price is below the 200-day average.

In Q2 FY2027 (quarter ended July 26, 2026), NVIDIA reported revenue of $96.2 billion (up 106% year over year), Data Center revenue of $89.0 billion (up 117%) and a 75.0% gross margin, but GAAP diluted EPS of $2.46 exceeded non-GAAP EPS of $2.22 largely because of about $7.8 billion of pre-tax gains on equity investments, a non-operating item that should be normalized out.

High confidence

The SEC-filed 8-K press release dated August 26, 2026 states the revenue, Data Center, margin and GAAP and non-GAAP EPS figures. OANDA cites the roughly $7.8 billion of equity-investment gains, plus free cash flow of $21.3 billion, which grew about 59% compared with revenue growth of 106%.

At about $163, NVDA trades at a trailing P/E of about 20.6, a forward P/E of about 13.5, a price-to-book of 17.5 and an EV/EBITDA of 19.3, on trailing-twelve-month revenue of $302.97 billion and TTM EPS of $7.91.

Medium confidence

StockAnalysis lists trailing P/E 20.59, forward P/E 13.46, P/B 17.53 and EV/EBITDA 19.30. Macrotrends shows a trailing P/E of 20.77 as of Nov 12, and 24/7 Wall St. (via Yahoo Finance) cites about 13x forward EPS of $13.18. The forward P/E is rated medium because other articles in the search results quoted 16x to 25x, probably from older prices or different estimate bases.

Baird downgraded NVDA from Outperform to Neutral on November 11, 2026 and cut its price target 60%, from $500 to $200, about 13% above the roughly $177 midday share price that day.

High confidence

The Motley Fool reports the downgrade, the $500-to-$200 cut and the roughly 13% implied upside from about $177. Baird cited limited visibility into 2027 data-center supply, hyperscaler capex growth slowing to about 40% or less in 2027, and uncertainty over CEO Jensen Huang's tenure.

NVDA traded at about 10.7x consensus fiscal-2028 EPS of $15.75 (based on the $168.89 close on November 10, 2026), and FactSet's next-12-month forward P/E of about 11.7x is the lowest since October 2011, compared with about 18.7–20x for the S&P 500 and about 19x for Broadcom and 32x for AMD.

Medium confidence

FourWeekMBA calculates 10.7x from $168.89 / $15.75 and cites the FactSet 11.7x NTM figure as the lowest since Oct 2011, which is well below NVDA's own five-year range. Crypto Briefing gives the S&P 500 at 18.7–20x. The multiples are the outlets' own calculations, so the exact figure depends on the EPS period used.

The next catalyst is NVDA's fiscal Q3 2027 report on November 17, 2026 after the close (5 p.m. ET call), where consensus EPS is about $2.49 from 13 estimates; the main risks are CEO Jensen Huang's uncertain tenure amid a board investigation, possible 2027 hyperscaler capex deceleration, supply constraints, and data-center power regulation.

Medium confidence

FourWeekMBA reports the Nov 17 call time and $2.49 consensus EPS. The Fool reports the board investigation involving Huang and Baird's capex and supply concerns, and Crypto Briefing cites AI-infrastructure costs and power-related regulation as selloff drivers. Consensus targets may reset after the report.

As of mid-November 2026, Wall Street ratings on NVDA are overwhelmingly positive: one aggregator counts 10 Strong Buy, 49 Buy, 3 Hold, 1 Sell and 0 Strong Sell, and another reports that about 95% of covering analysts rate the stock a Buy.

Medium confidence

Options Analysis Suite gives the 10/49/3/1/0 split across 63 ratings, and 247wallst separately reports that 95% rate it a Buy. Both are secondary aggregators, and their analyst sets differ.

NVDA's quoted 52-week range is $148.81 to $243.37, which puts the Nov 13 close of about $162.85 roughly 9% above the 52-week low and about 33% below the 52-week high, so $148.81 is the nearest major support level.

Medium confidence

The aggregator lists a 52-week range of $148.81 to $243.37 and says the price has fallen 16.96% since a sell signal on Nov 4. The distances are calculated against StockAnalysis's Nov 13 close. These are secondary sources, and the range is likely based on intraday prices.

The November sell-off coincided with headlines about CEO Jensen Huang: Reuters reported that he told employees he had been unfaithful, the board opened an independent investigation into whether a foreign intelligence service targeted him, shares fell 4.3% on November 9 (about $190 billion of market value), and a shareholder lawsuit was filed after the close that day.

Medium confidence

OANDA's November 10, 2026 preview cites Reuters on the investigation, says NVIDIA had no reason to believe company secrets or U.S. national security were compromised, and describes the lawsuit as plaintiffs' allegations, not court findings. A Morningstar headline reports Huang's resignation with CFO Colette Kress as interim CEO, but another headline says his future is still undecided and no primary source confirmed the resignation, so a leadership change remains unverified.

NVDA's annual dividend is $1.00 per share, a 0.61% yield, which StockAnalysis lists as 1,200% growth from a year earlier, so the payout was raised, not cut.

Medium confidence

StockAnalysis lists an annual dividend of $1.00, a yield of 0.61% and 1,200% year-over-year dividend growth. The date and quarterly amount of the increase were not confirmed against an NVIDIA press release, so this rests on one secondary source.

NVIDIA generated $127.01 billion of trailing-twelve-month free cash flow and holds $62.47 billion of cash against $38.86 billion of total debt, a net cash position of about $23.61 billion.

Medium confidence

StockAnalysis's balance-sheet and cash-flow fields show FCF (TTM) of $127.01B, cash of $62.47B, debt of $38.86B and net cash of $23.61B. These figures were not cross-checked against the latest 10-Q. The 24/7 Wall St. article also notes about $50B invested in frontier AI labs and days-sales-outstanding rising to 60 days, both of which bear on cash-flow quality.

On November 12, 2026, several brokers cut NVDA price targets, including BofA Securities from $350 to $280 and Goldman Sachs from $300 to $220, while Benzinga lists a consensus price target of $290.44, about 78% above the Nov 13 close.

Medium confidence

Benzinga's quote and analyst-ratings page lists the November 12 target changes and the $290.44 consensus. The upside percentage is calculated against the $162.85 close. This is a secondary aggregator, and the firms' original notes were not reviewed.

Against its peer AMD, NVDA's forward P/E of about 13x is roughly half of AMD's 27x as of November 13, 2026; the comparison with NVDA's own 5-year multiple range could not be checked from a current source.

Low confidence

The Nov 13 24/7 Wall St. article states AMD trades at 27x forward earnings versus NVIDIA at 13x. Other secondary articles in the results put AMD at 33x to 40x. The Macrotrends historical P/E series returned HTTP 403, so no sourced 5-year average or range is available, and no claim is made that current multiples sit at a 5-year low.

Sources (36)

Caveats

Time sensitivity: this report is as of Nov 14, 2026, three days before the Nov 17 Q3 FY2027 report [2]. Price, technical readings, multiples and analyst targets are likely to change materially after that release, and consensus targets may reset [14]. Price inputs differ by date: the $162.85 close of Nov 13 [8], the roughly $177 midday price on Nov 11 behind several upside figures [6][12], and the $168.89 close of Nov 10 behind the 10.7x FY2028 multiple [13]. Data conflicts: (1) Goldman Sachs is reported as reiterating Buy/$300 on Nov 9 [6] but also as cutting its target to $220 on Nov 12 [20]. These are irreconcilable without the original note, which was not reviewed. (2) Consensus price targets vary from $271.64 to $326.92 across aggregators that update at different times [4][20]. (3) Estimates of the 50-day moving average range from about $181 to $221 [5][9], and RSI(14) from about 24.9 to 41.5 [5][9]. (4) Forward P/E figures range from about 10.7x to 13.5x depending on the EPS period and price used [11][13], and AMD's forward multiple is quoted between 27x and 40x [13][21]. Five-year valuation history is only partly sourced. FactSet's lowest-since-2011 figure comes through a secondary outlet [13], and a direct 5-year P/E series could not be retrieved [21], so no independently verified 5-year range is given. Source quality: only the Q2 results and Q3 guidance come from a primary SEC-filed 8-K [2][10]. Ratings tallies, targets, balance-sheet, free-cash-flow and dividend figures come from secondary aggregators and were not cross-checked against the 10-Q or company releases [4][15][18][19][20]. The 1,200% dividend-growth figure in particular rests on a single aggregator [18]. The Citi cut comes from aggregator coverage only [6], and no recent actions by JPMorgan or Barclays could be verified [6]. Governance: the Huang investigation and lawsuit are based on media reports and plaintiffs' allegations, not findings, and his reported resignation is unconfirmed by any primary source [17]. Gaps: clean 6-month and 12-month returns could not be confirmed [8]. China revenue exposure is not quantified beyond its exclusion from guidance [1][2]. Segment detail beyond Data Center, options positioning, insider activity and short interest are not covered. This is not a buy, sell or hold recommendation.

This report is for informational purposes only and is not investment advice. No buy / sell / hold recommendation is made or implied.

More research reports

Recent reports from the same pipeline. See all examples

Want this on your watchlist?

Add your own focus, pick a delivery speed, and get a source-verified report like this one.